Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer’s disease-Reference-Cited by-同舟云学术

Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer’s disease

Published:2018-05 Issue: Volume:676 Page:71-77
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Kumar Abhai,Singh Smita,Verma Ashish,Mishra Vijay Nath

Funder

Science and Engineering Research Board, New Delhi

Publisher

Elsevier BV

Subject

General Neuroscience

Reference38 articles.

1. Conceptual issues;Petersen,2003

2. Current concepts in mild cognitive impairment;Petersen;Arch. Neurol.,2001

3. Cerebral amyloid-[4]β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study;Barthel;Lancet Neurol.,2011

4. Biomarker of Alzheimer disease in plasma;Irizarry;J. Am. Soc. Exp. Neuro Ther.,2004

5. Identifying and validating biomarkers for Alzheimer’s disease;Humpel;Trends Biotechnol.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Diagnosis of Alzheimer′s Disease with Blood Test; Tempting but Challenging;INT J MOL CELL MED;2023

2. Proteomic Markers and Early Prediction of Alzheimer’s Disease;Biochemistry (Moscow);2022-08

3. Prognosis of Alzheimer’s Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning;International Journal of Molecular Sciences;2022-07-18

4. Machine Learning for Mass Spectrometry Data Analysis in Proteomics;Current Proteomics;2021-11-23

5. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases;Current Neuropharmacology;2021-08-11